Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4

Diabetes Mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004

(2008) Adam T. Whaley-Connell et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004

(2008) Madhav V. Rao et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes

(2008) N. Stefan et al.   DIABETES

Hierarchical Role of Fetuin-A and Acidic Serum Proteins in the Formation and Stabilization of Calcium Phosphate Particles

(2008) Alexander Heiss et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

C-reactive protein and coronary heart disease: a critical review

(2008) J. P. Casas et al.   JOURNAL OF INTERNAL MEDICINE

Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus

(2008) Katsuhito Mori et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis

(2008) R. C. Shroff et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients

(2007) K. Caglar et al.   Clinical Journal of the American Society of Nephrology

Mechanisms of Vascular Calcification in Chronic Kidney Disease

(2007) S. M. Moe et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Exploring the biology of vascular calcification in chronic kidney disease: What's circulating?

(2007) M. Schoppet et al.   KIDNEY INTERNATIONAL